Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Genetic Diseases, Inborn × FANG vaccine × Plasma cell × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Other hematologic neoplasm 1

Conditions

Multiple Myeloma 3 Neoplasms, Plasma Cell 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms 1 Leukemia, Myeloid, Acute 1 Leukemia 1 Hematologic Neoplasms 1 Genetic Diseases, Inborn 1 Congenital Abnormalities 1

Interventions

Melphalan 2 sargramostim 1 keyhole-limpet hemocyanin 1 ixazomib 1 FANG vaccine 1 Clinical Trials, Phase II as Topic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00019097 2024-03-04

Vaccine Therapy in Treating Patients With Multiple Myeloma

National Cancer Institute (NCI)

Phase 2 Completed

Other hematologic neoplasmPlasma cell

Multiple Myeloma, Neoplasms, Hematologic Neoplasms, Genetic Diseases, Inborn, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡